Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs Ristia Bintang Mahkotasejati Tbk. (RBMS) Price & Performance

Diagnos Laboratorium Utama Tbk.Trade
Ristia Bintang Mahkotasejati Tbk.Trade

Price performance (Past 24H)

Key statistics

Diagnos Laboratorium Utama Tbk. vs Ristia Bintang Mahkotasejati Tbk. — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Ristia Bintang Mahkotasejati Tbk. trades at Rp58 (market cap 156.72B, 22.04M 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is the larger of the two by market cap, and Ristia Bintang Mahkotasejati Tbk. is more actively traded (22.04M versus 963.6K). Which is the better fit depends on your goals.

DGNSRBMS
Market Cap
310.75B156.72B
Volume
963.6K22.04M
Lot
9.64K220.37K
Turnover
217.67M1.28B
Average Price
225.8958.3
Value
217.67M1.28B
Indicative Equilibrium Price
22658
Indicative Equilibrium Volume
1K12.8K

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DGNS
View details
RBMS
View details

About Diagnos Laboratorium Utama Tbk.

PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.

Read more on DGNS

About Ristia Bintang Mahkotasejati Tbk.

PT Ristia Bintang Mahkotasejati Tbk (the Company) was established based on the Notarial Deed No. 114 of Lieke Lianadevi Tukgali, S.H., dated May 22, 1985. PT. Ristia Bintang Mahkotasejati is a Real Estate developer and contractor. A company developing houses, store houses and also facilities supported in Bekasi, Tanggerang and Karawang.

Read more on RBMS